Search Results

This study addresses the virtual optimization of the technical specifications for a recently developed Advanced Pedestrian Legform Impactor (aPLI). The aPLI incorporates a number of enhancements for improved lower limb injury predictability with respect to its predecessor, the FlexPLI. It also incorporates an attached Simplified Upper Body Part (SUBP) that enables the impactor’s applicability to evaluate pedestrian’s lower limb injury risk also with high-bumper cars. The response surface methodology was applied to optimize both the aPLI’s lower limb and SUBP specifications, while imposing a total mass upper limit of 25 kg that complies with international standards for maximum weight lifting allowed for a single operator in the laboratory setting. All parameters were virtually optimized considering variable interaction, which proved critical to avoid misleading specifications.

A biofidelic flexible pedestrian leg-form impactor, called Flex-PLI, was developed by the Japan Automobile Manufactures Association, Inc. (JAMA) and the Japan Automobile Research Institute (JARI). Its latest version is called Flex-PLI 2003. The Flex-PLI 2003 responses have been validated at the component level (thigh, leg, and knee independently) but not at the assembly level (thigh-knee-leg complex). Furthermore, there was no FE Flex-PLI model. This research developed a FE Flex-PLI 2003R model (Flex-PLI 2003R means that the thigh and leg mass of Flex-PLI 2003 is adjusted to AM 50). The FE Flex-PLI 2003R model biofidelity has been evaluated at both the component level and the assembly level, where it demonstrated high biofidelity.

JAMA-JARI has developed a biofidelic flexible pedestrian leg-form impactor (Flex-PLI 2004) by making several modifications to the Flex-PLI 2003 to improve usability, durability and biofidelity. Biofidelity evaluation for the Flex-PLI 2004 was estimated at the component level (thigh, knee, and leg individually) as well as at the assembly level (thigh-knee-leg complex), using an objective impactor biofidelity evaluation system based on a method developed by Rhule et al. to eliminate any subjective prejudice in an impactor biofidelity evaluation. Applying the biofidelity evaluation system to the Flex-PLI 2004, the average impactor biofidelity rank (IBR) score became 1.22 at the component level and 1.26 at the assembly level. These IBR scores mean that the Flex-PLI 2004 has good biofidelity at the component level as well as at the assembly level.